Guangzhou Hexin Instrument Hits Day High with 13.14% Surge

Guangzhou Hexin Instrument Co., Ltd. has experienced significant activity today, with the stock surging by 13.14% on October 15, 2025. The stock reached an intraday high of CNY 140.87, showcasing its strong performance against the backdrop of the China Shanghai Composite, which declined by 0.62% on the same day.
Over the past week, Guangzhou Hexin has demonstrated remarkable growth, with a 29.15% increase, and a staggering 42.55% rise over the past month. Year-to-date, the stock has gained 120.26%, and its impressive one-year performance stands at 495.45%, significantly outpacing the broader market's 17.69% increase.

Despite these gains, the company faces challenges, including operating losses and a high debt-to-equity ratio of 0.57. Recent financial results indicate a decline in net sales and pre-tax profit, raising concerns about long-term growth potential. The stock's performance metrics reflect a complex picture, with substantial returns juxtaposed against underlying financial difficulties. As a mid-cap player in the pharmaceuticals and biotechnology sector, Guangzhou Hexin continues to navigate a dynamic market landscape.